liposomal glutathione parkinson& 39 Innovative approach in Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Revamping Parkinson's disease therapy using
Revamping Parkinson's disease therapy using PLGA based drug delivery systems PMC Frontiers Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives Dual pathway targeted therapy for Parkinson's disease: Biomimetic nanosomes inhibit ferroptosis and pyroptosis through NLRP3 inflammasome regulation ScienceDirect Research progress on intranasal treatment for Parkinson's disease Neuroprotection
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



